Adam Schayowitz
Vice President, Development Head, Breast Cancer, Colorectal Cancer and Melanoma

Global Development Team Lead responsible for developing the strategy and overseeing the cross-functional implementation of the BRAF/MEK franchise in CRC, melanoma and NSCLC for Pfizer Oncology.

Responsible for managing the ARRAY integration ($11.4B acquisition by Pfizer) and the establishment and implementation of the Global Medicine Team. Conceptualized, planned and implemented three global registration programs as well as four Phase 1 and 2 programs supporting registration, commercialization and life cycle management.

Co-Chair of the Joint Steering Committee (JSC) and Joint Development Committees (JDC) with Pierre Fabre and Ono. Responsible for a $150M+ annual budget and a franchise with a peak commercial value of $2Bn globally.